Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03552055 · ClinicalTrials.gov registry record
Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation
A clinical trial of Gestational Age, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- 245
- Enrollment target
- 2
- Study locations
NCT03552055: Completed study of Gestational Age, sponsored by Gynuity Health Projects.
NCT03552055 is a study of Gestational Age that has completed, run by Gynuity Health Projects. The registered enrollment target is 245 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03552055, a study of Gestational Age, has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- 245 participants
- Enrollment target
- 2
- Study locations
Study Summary
Investigators will collect serum and urine specimens from pregnant patients along the full pregnancy continuum, assay each specimen for selected placental proteins, and examine the relationships between concentrations of the proteins and gestational age as determined by ultrasound.
Primary Outcome
Concentration of placental proteins in blood and urine
Conditions Studied
Interventions
- OTHER Non-interventional Study
Study Locations (2)
Pennsylvania
- University of Pennsylvania - Philadelphia
- Planned Parenthood of Southeastern Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2017-05-24 |
| Est. Completion | 2019-09-30 |
What the finished NCT03552055 record still lists
NCT03552055 is an observational study that tracks outcomes without assigning an intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Gestational Age appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional Study is the first listed.
NCT03552055 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03552055 about?
NCT03552055 is a clinical study titled "Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation". Investigators will collect serum and urine specimens from pregnant patients along the full pregnancy continuum, assay each specimen for selected placental proteins, and examine the relationships between concentrations of the proteins and gestational age as determined by ultrasound.
What is the current status of trial NCT03552055?
This trial is currently completed. The enrollment target is 245 participants. The study started on 2017-05-24. Estimated completion is 2019-09-30.
What conditions does trial NCT03552055 study?
This clinical trial studies the following conditions: Gestational Age.
What interventions are being tested in trial NCT03552055?
The interventions under investigation include: Non-interventional Study (OTHER).
Who is sponsoring clinical trial NCT03552055?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03552055 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT05446259 · 245 participants
Degenerative Cervical Myelopathy Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI